Enzo Biochem Appoints Carl W. Balezentis, Ph.D., President Of Enzo Life Sciences Subsidiary
Enzo Biochem, Inc. announced the appointment of Carl W. Balezentis, Ph.D. to the newly created position of President of Enzo Life Sciences, Inc. Dr. Balezentis, a senior executive with 18 years experience in the life sciences industry, was CEO of Lark Technologies, Inc., prior to its acquisition by Genaissance Pharmaceuticals, Inc. Enzo Life Sciences, a wholly owned subsidiary of Enzo Biochem, develops, manufactures and markets biomedical research products, nonradioactive labeling and detection protocols, as well as reagents for molecular biology research, including microarray methodologies for both gene expression and genomic analysis applications.
After Lark Technologies' acquisition, Dr. Balezentis joined Genaissance (which itself was subsequently acquired) as Senior VP. He was responsible for the rapid integration of Lark's facilities in the US and UK into Genaissance, and developed sales and marketing strategies aimed at fully utilizing the resources of both companies and developing synergistic opportunities. He spent a total of five years with both companies.
Previously, Dr. Balezentis was Director of Business Development of the multi-million dollar Life Sciences Division of Sigma-Aldrich Inc, where he had global responsibility for developing, organizing and leading business development activities, after previously serving as VP Sales and Marketing of Genosys Biotechnologies, Inc., which was acquired by Sigma-Aldrich. He also served as Director of Marketing at Perceptive Scientific Instruments, Inc., acquired by International Remote Imaging Systems, and as Group Leader-Human Identity Products at Applied Biosystems, Inc. (now Applera Corporation).
Among other positions he has held, Dr. Balezentis was Director - Gene Identity at Promega Corporation, Chief Scientific Officer of Molecular Identity Testing, Inc.; and Scientific/Technical Director of Molecular Diagnostic Associates, Inc.
Dr. Balezentis holds a BS degree in Biology and a Ph.D. in Genetics from the University of Arizona, in Tucson, and a Post Doctoral Fellowship at M.D. Anderson Cancer Center, in Houston, TX. He was a co-founder and Board Member of the Human Identity Trade Association, in addition to chairing in 1992 and 1993 the International Symposium on Human Identity.
Other news from the department people
These products might interest you
Micro-Dx™ CE IVD by Molzym
Fully automated from sample to PCR analysis
Rapid identification of bacteria and fungi without time-consuming cultivation
DNA-free Taq Polymerases and Mastermixes by Molzym
DNA-free reagents for unrivalled sensitivity in molecular biology
Purity that makes the difference
CellGenix® Growth Factors and Cytokines by Sartorius
Recombinant growth factors without animal products
Optimised cell culture for T cells and MSCs in gene therapy
Recombumin® Elite by Sartorius
ICHQ7 cGMP-compliant albumin for biotechnological applications
Increase consistency and safety for gene therapies and vaccines
DNA/RNA Shield™ SafeCollect Collection Kits by Zymo Research
Sample collection devices for simple & safe at-home testing
Best user experience for secure self-collection
Greener Alternative Products by Merck Life Science
Sustainable laboratory products for environmentally conscious research
Over 2,500 ecological alternatives to reduce your laboratory footprint
